Back to UBS Group AG UBS Group AG

ACXPACXP
3 quarters

Position history for UBS Group AGUBS Group AG's holdings in ACURX PHARMACEUTICALS INC

UBS Group AG holds 3 shares of ACXP (ACURX PHARMACEUTICALS INC), worth $5 as of 2026-Q2. The position was decreased (-100.0% shares).

Current Value

$5

Current Shares

3

Total Value Change

-$415

Total Shares Change

-166

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
3
-100.0%
$50.0%$1.55
0
2026-Q1
Increased
6,312
+3634.9%
$23,4180.0%$1.48
21
2025-Q4
New
169
-
$4200.0%$2.62
17

Other major holders of ACXP: JANE STREET GROUP, LLC, VANGUARD CAPITAL MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used